• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/5

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

5 Cards in this Set

  • Front
  • Back
Categorization of hematologic malignancies: Leukemia, Lymphoma
1. Leukemia: Acute (acute myeloid leukemia, acute lymphoblastic leukemia), Chronic (chronic myeloid leukemia, chronic lymphocytic leukemia)
Lymphoma: Hodgkin's lymphoma (sub-types, non-Hodgkin's lymphoma (subtypes)
Major features of: leukemia, lymphomas
1. Leukemia: bone marrow and peripheral blood, Chronic (insidious, less aggressive, more mature cells) or Acute (rapid, aggressive, immature blasts)
2. Lymphoma: no involvement of peripheral blood, arise from discrete mass
Lab Evaluation of Hematologic Malignancies: Morphology, Cytochemistry, Immunocytochemistry, Cytogenetics, Molecular Genetics
1. Morphology: identify type of cell
2. Cytochemistry: Stains help to classify lineage of leukemic cell
3. Immunocytochemistry: differentiate between types subtypes (ALL vs AML, different lymphoid malignancies in same lymph node), Flow cytometry, Immunostaining
4. Cytogenetics: look for deletions, translocations, aneuploidy, amplifications by karyotype and FISH
5. Molecular Genetics: detect fusion transcripts/mutations and do lymphocyte clonality testing using PCR and protein electrophoresis
Chromosome Aberrations: How they arise, Information they provide, Types, Examples
1. How They Arise: Random (most), Genotoxic agents
2. Information They Provide: diagnosis, prognosis, response to therapy
3. Types: deletions, translocations, aneuploidy, amplifications (double minutes, homogenously staining regions)
Examples: MYC translocations in Burkitt Lymphoma, Philadelphia chromosome (t(9;22)) in CML (ABL-BCR), t(15;17) in acute promyelocytic leukemia (PML-RARA)
How can you prove clonality (ie-prove neoplasm over reactive process)?
1.Acquired clonal cytogenetic abnormality - by karyotype/FISH
2. New fusion gene (ex-Bcr-Abl) - by PCR
3. Kappa or lambda light chain restriction in Bcells - by PCR or protein electrophoresis
4. Ig gene rearrangements in B cells or T cells - PCR or Protein electrophoresis